Welcome to YLOAN.COM
yloan.com » Marketing » Acute Ischemic Stroke - Drug Pipeline Analysis And Market Forecasts To 2015
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Acute Ischemic Stroke - Drug Pipeline Analysis And Market Forecasts To 2015

Summary

Summary

The industry analysis specialists new report, Acute Ischemic Stroke Drug Pipeline Analysis and Market Forecasts to 2015 is an essential source of information and analysis on the global Acute Ischemic Stroke (AIS) market. The report identifies the key trends shaping and driving the global AIS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global AIS sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.

Scope

The scope of the report includes:

- Annualized global AIS market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.

- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. The pipeline candidates fall under the major categories like thrombolytics, neuroprotectants, anticoagulants, antiplatelets.

- Analysis of the current and future market competition in the global AIS market. Key future market players covered are Lundbeck, ThromboGenics and Vernalis holding the molecules that can directly treat the acute phase of the disease in the pipeline. Apart from these companies, Bayer, Bristol-Myers Squibb and Boehringer Ingelheim are found to be the companies with noticeable Phase III molecules for conditions like stroke prevention in atrial fibrillation.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with AIS.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global AIS market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global AIS market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- Whats the next big thing in the global AIS market landscape? Identify, understand and capitalize.

Companies Mentioned

Genentech, Boehringer Ingelheim, Kyowa Hakko, Mitsubishi Pharma, Lundbeck, PAION Deutschland GmbH, ThromboGenics, Vernalis plc., D-Pharm, Ferrer International S.A., Bayer, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Bristol-Myers Squibb, Pfizer

To know more about this report & to buy a copy please visit :

http://www.visionshopsters.com/product/2127/Acute-Ischemic-Stroke-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2015.html

Contact us:

Visionshopsters


Ph : 91-22-40583000

Emailid: marketing@visionshopsters.com

Website : www.visionshopsters.com

by: Visionshopsters
Creating Videos For Videos Marketing Aarkstore Enterprise - Infrastructure Management Outsourcing Vendors-aarkstore Enterprise Market R Will Mlmleadsystempro Help You Succeed The Perfect Marketing System Ivybot Could Make Your Forex Trading Successful And Profitable Effective Online Blog Marketing Strategies That Eventually Guarantee Blogging Success 7 Market Timing Signal Strategies for Stock Market Investment Timing Important Tips To Making Profit Via Online Forex Cheap Shoes Shopping On Myshoepermarket.com Day trading forex currency earns unexpected profits Crucial Blog Marketing Strategies That Will Generate Traffic And Online Presence Double Edged Fat Loss 2.0 Review - Kareem Samhouri Scam? Blog Promotion Marketing In Relation To Customer Relation And Building Online Image Blog Marketing Strategies That Guarantee Targeted Traffic And Traffic Retention
print
www.yloan.com guest:  register | login | search IP(216.73.216.140) California / Anaheim Processed in 0.010908 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 59 , 4129, 66,
Acute Ischemic Stroke - Drug Pipeline Analysis And Market Forecasts To 2015 Anaheim